US20170224653A1
University of Texas Southwestern
A TLR-independent adjuvant compound that corresponds in structure to Formula I, below, or its pharmaceutically acceptable salt is disclosed in which X, Y, Z, n, R 1 , R 2 , R 3 , R 4 and W are defined within. Also disclosed are a method of its preparation and use, as well as a pharmaceutical composition …